{
  "gene": "BPTF",
  "phenotype_entities": [
    {"name": "Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies", "source_mentions": ["OMIM"]},
    {"name": "Kaposi sarcoma, susceptibility to", "source_mentions": ["OMIM"]},
    {"name": "Disease-causing germline mutation(s) in BPTF-related intellectual disability-facial dysmorphism-skeletal anomalies syndrome", "source_mentions": ["ORPHANET"]},
    {"name": "Role in the phenotype of 17q24.2 microdeletion syndrome", "source_mentions": ["ORPHANET"]}
  ],
  "criteria_reasoning": {
    "assertions_made": {
      "verdict": "Multiple entities",
      "justification": "OMIM lists a neurodevelopmental syndrome (NEDDFL) and a separate cancer predisposition (Kaposi sarcoma susceptibility). Orphanet separately lists a BPTF-related ID–facial dysmorphism–skeletal anomalies syndrome and involvement in a 17q24.2 microdeletion syndrome."
    },
    "molecular_mechanism": {
      "verdict": "Distinct",
      "justification": "NEDDFL is attributed to haploinsufficiency from truncating/deleterious variants and deletions. Kaposi sarcoma susceptibility is reported with a specific missense variant and functional viral/oncogenic pathway effects, implying a different mechanism; microdeletion syndrome reflects contiguous gene loss."
    },
    "phenotypic_variability": {
      "verdict": "Distinct phenotypes",
      "justification": "NEDDFL shows variable expressivity within a consistent neurodevelopmental/dysmorphic spectrum. Kaposi sarcoma families lacked neurodevelopmental/dysmorphic features and present with tumor susceptibility, indicating a distinct clinical entity."
    },
    "mode_of_inheritance": {
      "verdict": "Same",
      "justification": "Both NEDDFL and Kaposi sarcoma susceptibility are described as autosomal dominant. Mode is not specified for the 17q24.2 microdeletion entity in Orphanet’s listing."
    }
  },
  "entity_decisions": [
    {"name": "Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies", "decision": "LUMP", "confidence": 0.95},
    {"name": "Disease-causing germline mutation(s) in BPTF-related intellectual disability-facial dysmorphism-skeletal anomalies syndrome", "decision": "LUMP", "confidence": 0.95},
    {"name": "Kaposi sarcoma, susceptibility to", "decision": "SPLIT", "confidence": 0.85},
    {"name": "Role in the phenotype of 17q24.2 microdeletion syndrome", "decision": "SPLIT", "confidence": 0.6}
  ],
  "proposed_groupings": [
    {
      "group_id": 1,
      "entities": [
        "Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies",
        "Disease-causing germline mutation(s) in BPTF-related intellectual disability-facial dysmorphism-skeletal anomalies syndrome"
      ],
      "proposed_label": "Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies",
      "mode_of_inheritance": "Autosomal dominant",
      "criteria_met": ["assertions", "molecular_mechanism", "phenotypic_variability", "mode_of_inheritance"],
      "reasoning": "OMIM and Orphanet describe the same developmental syndrome due to BPTF haploinsufficiency with variable expressivity; hence they represent a single entity.",
      "decision": "LUMP"
    },
    {
      "group_id": 2,
      "entities": ["Kaposi sarcoma, susceptibility to"],
      "proposed_label": "Kaposi sarcoma, susceptibility to",
      "mode_of_inheritance": "Autosomal dominant",
      "criteria_met": ["assertions", "molecular_mechanism", "phenotypic_variability"],
      "reasoning": "OMIM reports a distinct phenotype (tumor susceptibility without neurodevelopmental features) associated with a specific missense change and different functional effects.",
      "decision": "SPLIT"
    },
    {
      "group_id": 3,
      "entities": ["Role in the phenotype of 17q24.2 microdeletion syndrome"],
      "proposed_label": "Role in the phenotype of 17q24.2 microdeletion syndrome",
      "mode_of_inheritance": "Unknown/unclear",
      "criteria_met": ["assertions"],
      "reasoning": "Orphanet lists BPTF as contributory within a contiguous gene deletion syndrome rather than as a standalone monogenic BPTF disorder.",
      "decision": "SPLIT"
    }
  ],
  "overall_decision": {
    "verdict": "SPLIT",
    "summary_reasoning": "Authoritative sources delineate a BPTF haploinsufficiency neurodevelopmental syndrome and a separate autosomal dominant Kaposi sarcoma susceptibility linked to a specific missense variant with different functional consequences. The phenotypes are clinically distinct, while inheritance for the two main entities is autosomal dominant. The 17q24.2 microdeletion syndrome reflects a contiguous gene effect and should not be lumped with the monogenic BPTF syndrome.",
    "confidence": 0.86
  },
  "top_supporting_evidence": [
    "OMIM: \"The findings suggested that haploinsufficiency for BPTF is the pathogenic mechanism\" for NEDDFL.",
    "OMIM: \"In 5 immunocompetent individuals with classic Kaposi sarcoma... identified a heterozygous missense mutation... I2012T... All... had no features of a neurodevelopmental disorder or dysmorphic features.\"",
    "Orphanet: \"Disease-causing germline mutation(s) in BPTF-related intellectual disability-facial dysmorphism-skeletal anomalies syndrome\" and \"Role in the phenotype of 17q24.2 microdeletion syndrome.\""
  ],
  "suggested_action_for_curator": [
    "Verify whether additional evidence clarifies the molecular mechanism for the Kaposi sarcoma I2012T variant given its presence in population databases.",
    "Confirm that cases with 17q24.2 microdeletions are not being conflated with monogenic BPTF loss-of-function when curating the neurodevelopmental syndrome."
  ]
}